Ascentage Pharma appoints Dr. Veet Misra as CFO and Eric Huang as SVP of Global Corporate Development

Ascentage Pharma Group International announced the appointments of Veet Misra, Ph.D., as the Chief Financial Officer, and Mr. Eric Huang as Senior Vice President of Global Corporate Development and Finance. Both will report directly to Dr. Dajun Yang, the Chairman & CEO. Dr. Misra brings scientific and capital markets expertise, while Mr. Huang brings extensive experience in the global pharmaceutical industry. Ascentage Pharma is a dual-listed company on the Hong Kong Stock Exchange and Nasdaq, focused on becoming a leading global biopharmaceutical company. The company’s lead assets include olverembatinib and lisaftoclax for various hematologic malignancies.

Read more at GlobeNewswire: Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial